← FDA Drug Approvals (Drugs@FDA)

L-GLUTAMINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NOVITIUM PHARMA · Approved 2024-07-08

Drug application

FDA Application #
ANDA215647
Application type
Abbreviated New Drug Application (Generic)
Brand name
L-GLUTAMINE
Generic name
L-GLUTAMINE
Active ingredients
L-GLUTAMINE
Dosage form
FOR SOLUTION
Route
ORAL
Marketing status
Prescription
Sponsor
NOVITIUM PHARMA
Manufacturer
ANI Pharmaceuticals, Inc.
First approval
2024-07-08

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown